Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention
Background. The present study aimed to evaluate the prevalence and prognosis of residual lipid abnormalities in statin-treated acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). Subjects and Methods. A total of 3,047 ACS patients who underwent PCI and received sta...
Saved in:
Main Authors: | Bin Que, Chunmei Wang, Hui Ai, Xinyong Zhang, Mei Wang, Shaoping Nie |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/6175948 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heparin and Bivalirudin in Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Review Article
by: Guiping Wang, et al.
Published: (2024-01-01) -
The Rise of Transradial Artery Access for Percutaneous Coronary Intervention in Patients with Acute Coronary Syndromes in Australia
by: Ryan James Ocsan, et al.
Published: (2020-01-01) -
Balloon Occlusion Types in the Treatment of Coronary Perforation during Percutaneous Coronary Intervention
by: Xiangfei Wang, et al.
Published: (2014-01-01) -
Echocardiographic Parameters as Predictors of In-Hospital Mortality in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Miroslava Sladojevic, et al.
Published: (2014-01-01) -
Prolonged femoral compression post percutaneous coronary intervention leading to deep vein thrombosis
by: Amer Abu-Shanab, et al.
Published: (2025-01-01)